NM_000061.3:c.1926delC
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000061.3(BTK):c.1926delC(p.Thr643LeufsTer6) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000061.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- Bruton-type agammaglobulinemiaInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, ClinGen
- isolated growth hormone deficiency type IIIInheritance: XL Classification: STRONG, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTK | NM_000061.3 | c.1926delC | p.Thr643LeufsTer6 | frameshift_variant | Exon 19 of 19 | ENST00000308731.8 | NP_000052.1 | |
BTK | NM_001287344.2 | c.2028delC | p.Thr677LeufsTer6 | frameshift_variant | Exon 19 of 19 | NP_001274273.1 | ||
BTK | NM_001287345.2 | c.1398delC | p.Thr467LeufsTer6 | frameshift_variant | Exon 17 of 17 | NP_001274274.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
X-linked agammaglobulinemia with growth hormone deficiency Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Thr643Leufs*6) in the BTK gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 17 amino acid(s) of the BTK protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with BTK-related conditions. This variant disrupts a region of the BTK protein in which other variant(s) (p.Phe644Ser) have been determined to be pathogenic (PMID: 8695804, 32552675). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at